At Eyecelerator, Riad Sherif, MD, Oculis’ Chief Executive Officer, will provide an update on the Company’s innovative late-stage pipeline. About Acute Optic NeuritisAcute Optic Neuritis (AON) is a rare condition characterized by an acute inflammation of the optic nerve that can lead to permanent visual impairment. About Non-arteritic Anterior Ischemic Optic NeuropathyNon-arteritic Anterior Ischemic Optic Neuropathy (NAION) is an acute optic nerve disorder and the most common cause of acute optic nerve injury in individuals over 50 years old3. NAION and Acute Optic Neuritis (AON) injure the optic nerve leading to progressive axonal loss and visual decline, after the acute event. About OCS-01 eye drops and the OPTIREACH ® technologyLeveraging Oculis’ proprietary technology, OCS-01 is an OPTIREACH® formulation of high concentration dexamethasone eye drop.